Literature DB >> 26284558

Reactivation of the PI3K/Akt Signaling Pathway by the Bisperoxovanadium Compound bpV(pic) Attenuates Photoreceptor Apoptosis in Experimental Retinal Detachment.

Dan Mao, Xiaodong Sun.   

Abstract

PURPOSE: Phosphatase and tensin homology deleted on chromosome 10 (PTEN) is crucial in neuronal apoptosis. This study evaluated the role of PTEN in photoreceptor cell apoptosis caused by retinal detachment (RD).
METHODS: A rat model of RD was established, and PTEN expression changes were detected at different time points by Western blotting and immunofluorescence. Some of the rats were given subretinal injections of bisperoxovanadium compound (bpV[pic]) after RD. We documented the expression and distribution of phospho-Akt (p-Akt) and B-cell lymphoma 2 (Bcl-2) in the retina by Western blot analysis and immunofluorescence. Levels of phosph-phosphoinositide-dependent kinase 1 (p-PDK1), phospho-Bcl-2 death promotor (p-BAD), cytosolic cytochrome c (Cyt c), and cleaved Caspase-3 were detected by Western blotting. We measured phosphatidylinositol 3,4,5-triphosphate (PIP3) by ELISA. Apoptosis of photoreceptors was detected using the TUNEL assay. The thickness of the outer nuclear layer (ONL) also was recorded.
RESULTS: The expression of PTEN gradually increased after RD, peaking at 3 days and then decreasing to normal by 7 days after RD. Subretinal injection of bpV(pic) effectively reduced the apoptosis of photoreceptors and preserved the retinal thickness of the ONL after RD. Compared to vehicle-treated RD groups, levels of p-Akt and p-PDK1 were significantly upregulated in bpV-treated RD groups. In addition, bpV treatment increased the levels of p-BAD and Bcl-2, and decreased the expression levels of cytosolic Cyt c and cleaved caspase-3 after RD.
CONCLUSIONS: Phosphatase and tensin homology deleted on chromosome 10 (PTEN) participates in the apoptosis of photoreceptors after RD. Blocking PTEN may reactivate the PI3K/Akt pathway and attenuate photoreceptor apoptosis by suppressing the mitochondrial pathway.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26284558     DOI: 10.1167/iovs.15-16757

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  7 in total

1.  Pharmacological PTEN inhibition: potential clinical applications and effects in tissue regeneration.

Authors:  Gabriel A Borges; Liana P Webber; Ana Elizia M Marques; Eliete Ns Guerra; Rogerio M Castilho; Cristiane H Squarize
Journal:  Regen Med       Date:  2020-03-30       Impact factor: 3.806

2.  Inhibition of PTEN Attenuates Endoplasmic Reticulum Stress and Apoptosis via Activation of PI3K/AKT Pathway in Alzheimer's Disease.

Authors:  Weigang Cui; Songtao Wang; Zhongping Wang; Zhiyong Wang; Chunli Sun; Yinghua Zhang
Journal:  Neurochem Res       Date:  2017-08-18       Impact factor: 3.996

Review 3.  Metabolism Dysregulation in Retinal Diseases and Related Therapies.

Authors:  Yingying Chen; Nathan J Coorey; Meixia Zhang; Shaoxue Zeng; Michele C Madigan; Xinyuan Zhang; Mark C Gillies; Ling Zhu; Ting Zhang
Journal:  Antioxidants (Basel)       Date:  2022-05-11

4.  PDK1 regulates the survival of the developing cortical interneurons.

Authors:  Yongjie Wei; Xiaoning Han; Chunjie Zhao
Journal:  Mol Brain       Date:  2020-05-04       Impact factor: 4.041

5.  Role of Translational Attenuation in Inherited Retinal Degeneration.

Authors:  Christopher R Starr; Cyril N A Nyankerh; Xiaoping Qi; Yang Hu; Oleg S Gorbatyuk; Nahum Sonenberg; Michael E Boulton; Marina S Gorbatyuk
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-11-01       Impact factor: 4.799

6.  Prognostic and Functional Analysis of NPY6R in Uveal Melanoma Using Bioinformatics.

Authors:  ShiMin Mei; Yue Li; Xueran Kang
Journal:  Dis Markers       Date:  2022-04-08       Impact factor: 3.464

Review 7.  PTEN Inhibition in Human Disease Therapy.

Authors:  Rafael Pulido
Journal:  Molecules       Date:  2018-01-30       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.